Breast Cancer: Targets and Therapy, Volume 8, Issue (2016)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Breast Cancer: Targets and Therapy, Volume 8, Issue (2016)

See all volumes and issues
Vol 16, 2024 Vol 15, 2023 Vol 14, 2022 Vol 13, 2021 Vol 12, 2020 Vol 11, 2019 Vol 10, 2018 Vol 9, 2017 Volume 8, 2016 Vol 7, 2015 Vol 6, 2014 Vol 5, 2013 Vol 4, 2012 Vol 3, 2011 Vol 2, 2010 Vol 1, 2009
Download citations Download PDFs Download issue

Review

Review Article
Managing breast cancer in younger women: challenges and solutions
Foluso O Ademuyiwa, Amy Cyr, Jennifer Ivanovich & Maria A Thomas
Pages: 1-12
Published online: 28 Sep 2022
AbstractforManaging breast cancer in younger women: challenges and solutions | Full Text | References | PDF (547.7 KB)
  • 254 Views
  • 8 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer
Tineke Casneuf, Amy E Axel, Peter King, John D Alvarez, Jillian L Werbeck, Tinne Verhulst, Karin Verstraeten, Brett M Hall & A Kate Sasser
Pages: 13-27
Published online: 28 Sep 2022
AbstractforInterleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer | Full Text | References | PDF (1.8 MB)
  • 178 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access

Methodology

Article
Identification and prioritization of candidate genes for symptom variability in breast cancer survivors based on disease characteristics at the cellular level
Theresa A Koleck & Yvette P Conley
Pages: 29-37
Published online: 28 Sep 2022
AbstractforIdentification and prioritization of candidate genes for symptom variability in breast cancer survivors based on disease characteristics at the cellular level | Full Text | References | PDF (1.1 MB)
  • 84 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Astym therapy improves function and range of motion following mastectomy
Claire C Davies, Dorothy Brockopp & Krista Moe
Pages: 39-45
Published online: 28 Sep 2022
AbstractforAstym therapy improves function and range of motion following mastectomy | Full Text | References | PDF (515.4 KB)
  • 330 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Article
Factors affecting local recurrence and distant metastases of invasive breast cancer after breast-conserving surgery in Chiang Mai University Hospital
Chagkrit Ditsatham, Areewan Somwangprasert, Kirati Watcharachan, Phanchaporn Wongmaneerung & Jiraporn Khorana
Pages: 47-52
Published online: 28 Sep 2022
AbstractforFactors affecting local recurrence and distant metastases of invasive breast cancer after breast-conserving surgery in Chiang Mai University Hospital | Full Text | References | PDF (532.1 KB)
  • 97 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Breast cancer characteristics in very young Egyptian women ≤35 years
Omar Farouk, Mohamed A Ebrahim, Ahmad Senbel, Ziad Emarah, Waleed Abozeed, Mohamed O Seisa, Summer Mackisack, Salah Abdel Jalil & Safaa Abdelhady
Pages: 53-58
Published online: 28 Sep 2022
AbstractforBreast cancer characteristics in very young Egyptian women ≤35 years | Full Text | References | PDF (403.7 KB)
  • 204 Views
  • 11 CrossRef citations
  • 0Altmetric
Open Access
Article
Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent
Katherine E Hanlon, Alysia N Lozano-Ondoua, Puja J Umaretiya, Ashley M Symons-Liguori, Anupama Chandramouli, Jamie K Moy, William K Kwass, Patrick W Mantyh, Mark A Nelson & Todd W Vanderah
Pages: 59-71
Published online: 28 Sep 2022
AbstractforModulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent | Full Text | References | PDF (2.3 MB)
  • 191 Views
  • 11 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Pharmacologic management of bone-related complications and bone metastases in postmenopausal women with hormone receptor-positive breast cancer
Denise A Yardley
Pages: 73-82
Published online: 28 Sep 2022
AbstractforPharmacologic management of bone-related complications and bone metastases in postmenopausal women with hormone receptor-positive breast cancer | Full Text | References | PDF (264 KB)
  • 128 Views
  • 8 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Profile of palbociclib in the treatment of metastatic breast cancer
Moataz Ehab & Mohamad Elbaz
Pages: 83-91
Published online: 28 Sep 2022
AbstractforProfile of palbociclib in the treatment of metastatic breast cancer | Full Text | References | PDF (304.8 KB)
  • 242 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Triple-negative breast cancer: treatment challenges and solutions
Joëlle Collignon, Laurence Lousberg, Hélène Schroeder & Guy Jerusalem
Pages: 93-107
Published online: 28 Sep 2022
AbstractforTriple-negative breast cancer: treatment challenges and solutions | Full Text | References | PDF (342 KB)
  • 2534 Views
  • 82 CrossRef citations
  • 0Altmetric
Open Access
Article
Is radiation-induced ovarian ablation in breast cancer an obsolete procedure? Results of a meta-analysis
Mushabbab Al Asiri, Mutahir A Tunio & Reham Abdulmoniem
Pages: 109-116
Published online: 28 Sep 2022
AbstractforIs radiation-induced ovarian ablation in breast cancer an obsolete procedure? Results of a meta-analysis | Full Text | References | PDF (788 KB)
  • 141 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
The absence of aldehyde dehydrogenase 1 A1-positive cells in benign mammary stroma is associated with risk factors for breast cancer
Björn Logi Isfoss, Bo Holmqvist, Helena Jernström, Per Alm & Håkan Olsson
Pages: 117-124
Published online: 28 Sep 2022
AbstractforThe absence of aldehyde dehydrogenase 1 A1-positive cells in benign mammary stroma is associated with risk factors for breast cancer | Full Text | References | PDF (1.5 MB)
  • 89 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
A systematic review and meta-analysis of Harmonic technology compared with conventional techniques in mastectomy and breast-conserving surgery with lymphadenectomy for breast cancer
Hang Cheng, Jeffrey W Clymer, Nicole C Ferko, Leena Patel, Ireena M Soleas, Chris G Cameron & Piet Hinoul
Pages: 125-140
Published online: 28 Sep 2022
AbstractforA systematic review and meta-analysis of Harmonic technology compared with conventional techniques in mastectomy and breast-conserving surgery with lymphadenectomy for breast cancer | Full Text | References | PDF (829.7 KB)
  • 118 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Adjuvant systemic therapy in older women with breast cancer
Julieta Leone, Bernardo Amadeo Leone & José Pablo Leone
Pages: 141-147
Published online: 25 Jul 2016
AbstractforAdjuvant systemic therapy in older women with breast cancer | Full Text | References | PDF (181.8 KB)
  • 94 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Prevalence of CYP2D6*2, CYP2D6*4, CYP2D6*10, and CYP3A5*3 in Thai breast cancer patients undergoing tamoxifen treatment
Wanaporn Charoenchokthavee, Duangchit Panomvana, Virote Sriuranpong & Nutthada Areepium
Pages: 149-155
Published online: 08 Aug 2016
AbstractforPrevalence of CYP2D6*2, CYP2D6*4, CYP2D6*10, and CYP3A5*3 in Thai breast cancer patients undergoing tamoxifen treatment | Full Text | References | PDF (511.6 KB)
  • 98 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

Letter

Letter
Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “Triple-negative breast cancer: treatment challenges and solutions” by Collignon et al
Antonio Ieni, Valeria Barresi, Giuseppina Rosaria Rita Ricciardi, Barbara Adamo, Vincenzo Adamo & Giovanni Tuccari
Pages: 157-159
Published online: 19 Aug 2016
First Page PreviewforPrognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “Triple-negative breast cancer: treatment challenges and solutions” by Collignon et al | Full Text | References | PDF (126.1 KB)
  • 75 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Reducing infection risk in implant-based breast-reconstruction surgery: challenges and solutions
Adrian SH Ooi & David H Song
Pages: 161-172
Published online: 01 Sep 2016
AbstractforReducing infection risk in implant-based breast-reconstruction surgery: challenges and solutions | Full Text | References | PDF (1.1 MB)
  • 273 Views
  • 12 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Economic burden related to chemotherapy-related adverse events in patients with metastatic breast cancer in an integrated health care system
Nazia Rashid, Han A Koh, Hilda C Baca, Kathy J Lin, Susan E Malecha & Anthony Masaquel
Pages: 173-181
Published online: 04 Oct 2016
AbstractforEconomic burden related to chemotherapy-related adverse events in patients with metastatic breast cancer in an integrated health care system | Full Text | References | PDF (189.2 KB)
  • 255 Views
  • 25 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Current advances in biomarkers for targeted therapy in triple-negative breast cancer
Brett Fleisher, Charlotte Clarke & Sihem Ait-Oudhia
Pages: 183-197
Published online: 06 Oct 2016
AbstractforCurrent advances in biomarkers for targeted therapy in triple-negative breast cancer | Full Text | References | PDF (788.3 KB)
  • 322 Views
  • 13 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Statins and risk of breast cancer recurrence
Minas Sakellakis, Karolina Akinosoglou, Anastasia Kostaki, Despina Spyropoulou & Angelos Koutras
Pages: 199-205
Published online: 28 Sep 2022
AbstractforStatins and risk of breast cancer recurrence | Full Text | References | PDF (344.9 KB)
  • 150 Views
  • 10 CrossRef citations
  • 0Altmetric
Open Access

Letter

Letter
Are another 5 years of adjuvant aromatase inhibitor therapy needed?
Qin-Guo Mo, De-Quan Li, Jian-Hong Zhong & Chang-Yuan Wei
Pages: 207-209
Published online: 28 Sep 2022
First Page PreviewforAre another 5 years of adjuvant aromatase inhibitor therapy needed? | Full Text | References | PDF (142.4 KB)
  • 94 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Tumor suppressor ING4 inhibits estrogen receptor activity in breast cancer cells
Madeline M Keenen & Suwon Kim
Pages: 211-221
Published online: 17 Nov 2016
AbstractforTumor suppressor ING4 inhibits estrogen receptor activity in breast cancer cells | Full Text | References | PDF (994.9 KB)
  • 110 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
HMMR antisense RNA 1, a novel long noncoding RNA, regulates the progression of basal-like breast cancer cells
Wei Liu, Jun Ma, Yong Cheng, Hongbo Zhang, Wengguang Luo & Hongyan Zhang
Pages: 223-229
Published online: 24 Nov 2016
AbstractforHMMR antisense RNA 1, a novel long noncoding RNA, regulates the progression of basal-like breast cancer cells | Full Text | References | PDF (2.4 MB)
  • 106 Views
  • 12 CrossRef citations
  • 0Altmetric
Open Access
Article
Clinical effects of prior trastuzumab on combination eribulin mesylate plus trastuzumab as first-line treatment for human epidermal growth factor receptor 2 positive locally recurrent or metastatic breast cancer: results from a Phase II, single-arm, multicenter study
Shannon Puhalla, Sharon Wilks, Adam M Brufsky, Joyce O’Shaughnessy, Lee S Schwartzberg, Erhan Berrak, James Song & Linda Vahdat
Pages: 231-239
Published online: 07 Dec 2016
AbstractforClinical effects of prior trastuzumab on combination eribulin mesylate plus trastuzumab as first-line treatment for human epidermal growth factor receptor 2 positive locally recurrent or metastatic breast cancer: results from a Phase II, single-arm, multicenter study | Full Text | References | PDF (457.4 KB)
  • 95 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

Letter

Letter
Role of natural herbs and phytochemicals to minimize tumor and economic burden in breast cancer treatment
Maria Shoaib & Syed Ahsanuddin Ahmed
Pages: 241-242
Published online: 07 Dec 2016
CitationforRole of natural herbs and phytochemicals to minimize tumor and economic burden in breast cancer treatment | Full Text | References | PDF (130.9 KB)
  • 87 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Expression and functionality of TRPV1 in breast cancer cells
Lea V Weber, Klaudia Al-Refae, Gerhard Wölk, Gabriele Bonatz, Janine Altmüller, Christian Becker, Günter Gisselmann & Hanns Hatt
Pages: 243-252
Published online: 28 Sep 2022
AbstractforExpression and functionality of TRPV1 in breast cancer cells | Full Text | References | PDF (1.3 MB)
  • 328 Views
  • 37 CrossRef citations
  • 0Altmetric
Open Access

Explore articles

Explore the most recently published articles

The Prognostic Value of Serum Albumin to Globulin Ratio in Patients with Breast Cancer: A Retrospective Study
Chi Pan et al.
Article | Published online: 25 Jul 2024
Open Access
Brain Radiotherapy Combined with Targeted Therapy for HER2-Positive Breast Cancer Patients with Brain Metastases
Lifeng Tang et al.
Article | Published online: 23 Jul 2024
Open Access
Metabolomics in Radiotherapy-Induced Early Adverse Skin Reactions of Breast Cancer Patients
Alexandra N McMahon et al.
Article | Published online: 23 Jul 2024
Open Access
Predictive Value of Pretreatment Neutrophil to Albumin Ratio in Response to Neoadjuvant Chemotherapy of Breast Cancer
Yu-Xiang Deng et al.
Article | Published online: 23 Jul 2024
Open Access